| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/25/2004 | US20040055956 Includes valving to enable the excess diluent to move from the purification column into the output reservoir to provide removed diluent |
| 03/25/2004 | DE10243086A1 Electroporation chamber treating biological sample to introduce e.g. DNA, RNA or proteins into cells, has supply line with opening near electrode |
| 03/25/2004 | DE10242531A1 Altering several DNA sequences in moss, simultaneously, useful for preparing transformants for e.g. production of pharmaceuticals, using two or more homologous recombination constructs |
| 03/25/2004 | DE10242433A1 Chip carrying probes for specific genes, useful for rapid monitoring of organism status, particularly during fermentation |
| 03/25/2004 | DE10242319A1 New double-stranded oligonucleotides, useful for treating e.g. cardiovascular disease and arthritis, are decoys that lift inhibition of expression of endothelial nitric oxide synthase |
| 03/25/2004 | DE10241938A1 Selecting specific-bonding nucleic acid, by a modified SELEX process that includes purification by ultrafiltration to facilitate automation |
| 03/25/2004 | CA2799437A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2544124A1 Antibodies and methods for generating genetically altered antibodies with high affinity |
| 03/25/2004 | CA2538118A1 Sperm cell preservation and processing systems |
| 03/25/2004 | CA2500967A1 Transgenic cancer models in fish |
| 03/25/2004 | CA2499221A1 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | CA2498784A1 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | CA2498777A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | CA2498776A1 Gene expression system based on codon translation efficiency |
| 03/25/2004 | CA2498770A1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | CA2498746A1 Microarray synthesis and assembly of gene-length polynucleotides |
| 03/25/2004 | CA2498583A1 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | CA2498570A1 Particle for magnetically induced membrane transport |
| 03/25/2004 | CA2498523A1 Human cd3-specific antibody with immunosuppressive properties |
| 03/25/2004 | CA2498518A1 Apparatus and method for preparative scale purification of nucleic acids |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2498367A1 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | CA2498294A1 Transgenic expression cassettes for expressing nucleic acid sequences in sink tissues of plants that store carbohydrate |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 03/25/2004 | CA2498249A1 Ostertagia vaccine |
| 03/25/2004 | CA2498200A1 Construction of bacillus licheniformis t1 strain and fermentation production of crude enzyme extract therefrom |
| 03/25/2004 | CA2498196A1 Phenolic polymer nanotube and process for producing the same |
| 03/25/2004 | CA2498055A1 Aspartyl protease inhibitor as a nematode allergen |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497804A1 Human anti-human mcp-1 antibody and fragment of said antibody |
| 03/25/2004 | CA2497801A1 Paks as modifiers of the chk pathway and methods of use |
| 03/25/2004 | CA2497793A1 Flj20647s as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497790A1 Rors as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497356A1 Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3 |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | CA2497330A1 Novel compositions and methods for the treatment of immune-related diseases |
| 03/25/2004 | CA2497226A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 03/25/2004 | CA2497132A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | CA2496319A1 Mammalian megakaryocyte progenitor cell |
| 03/25/2004 | CA2496318A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2496317A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2495242A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/25/2004 | CA2494976A1 A sieve tube-localized glutathione s-transferase |
| 03/25/2004 | CA2494116A1 Adenoviral va1 pol iii expression system for rna expression |
| 03/24/2004 | EP1400601A1 Method for detection of multiple nucleic acid sequence variations |
| 03/24/2004 | EP1400599A1 Mass label linked hybridisation probes |
| 03/24/2004 | EP1400598A1 Method of assay of nucleic acid sequences |
| 03/24/2004 | EP1400596A1 Androgen receptor complex-associated protein |
| 03/24/2004 | EP1400593A1 Novel promoter |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1400591A1 Agent for treatment of exocrine gland disorders and transgenic mouse useful for screening the same |
| 03/24/2004 | EP1400590A1 Dna molecule with insulating activity against chromosomal position effects in gene transfer processes in animal cells |
| 03/24/2004 | EP1400589A1 Method for the enrichment of prokaryotic DNA |
| 03/24/2004 | EP1400588A1 POLYNUCLEOTIDE PROBE AND PRIMER ORIGINATING IN HEPATITIS E VIRUS OF JAPANESE, CHIPS HAVING THE SAME, KITS HAVING THE SAME AND METHOD OF DETECTING HEPATITIS E VIRUS USING THE SAME |
| 03/24/2004 | EP1400536A1 Method for making humanized antibodies |
| 03/24/2004 | EP1400534A1 Human CD3-specific antibody with immunosuppressive properties |
| 03/24/2004 | EP1400533A1 HASylated polypeptides, especially HASylated erythropoietin |
| 03/24/2004 | EP1400532A1 M. paratuberculosis specific ABC-transporter operon |
| 03/24/2004 | EP1400171A1 Transgenic production of antibodies in milk |
| 03/24/2004 | EP1399744A2 Epf receptor assays, compounds and therapeutic compositions |
| 03/24/2004 | EP1399739A2 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 03/24/2004 | EP1399593A2 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 03/24/2004 | EP1399592A1 Method to measure gene expression ratio of key genes |
| 03/24/2004 | EP1399591A2 Method for the determination of telomere length |
| 03/24/2004 | EP1399590A2 Happier mapping |
| 03/24/2004 | EP1399589A2 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders |
| 03/24/2004 | EP1399587A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 03/24/2004 | EP1399586A2 Method to identify genes associated with chronic myelogenous leukemia |
| 03/24/2004 | EP1399585A2 Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
| 03/24/2004 | EP1399584A2 Cancer-linked genes as targets for chemotherapy |
| 03/24/2004 | EP1399579A1 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 03/24/2004 | EP1399578A2 Adsls as modifiers of the p53 pathway and methods of use |
| 03/24/2004 | EP1399576A2 Test system for determining gene toxicities |
| 03/24/2004 | EP1399575A2 Methods of modifying eukaryotic cells |
| 03/24/2004 | EP1399574A2 Improved vectors for gene therapy |
| 03/24/2004 | EP1399573A2 Process of controlled shuffling of chromosome fragments for plant breeding |
| 03/24/2004 | EP1399572A2 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants |
| 03/24/2004 | EP1399571A2 Modulating developmental transitions in plants |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399569A2 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid |
| 03/24/2004 | EP1399568A2 Method for producing recombinant trypsin |
| 03/24/2004 | EP1399566A2 Novel glyphosate n-acetyltransferase (gat) genes |
| 03/24/2004 | EP1399565A2 Mitogenic oxygenase regulators |
| 03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
| 03/24/2004 | EP1399562A2 Complete nucleotide sequence of staphylococcus aureus ribosomal protein gene, s20 and methods for the identification of antibacterial substances |
| 03/24/2004 | EP1399561A2 Plant disease resistance genes |
| 03/24/2004 | EP1399560A2 Engineered human kunitz-type protease inhibitor |
| 03/24/2004 | EP1399559A2 Mouse lambda light chain locus |
| 03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 03/24/2004 | EP1399557A2 Brain expressed gene and protein associated with bipolar disorder |
| 03/24/2004 | EP1399556A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 03/24/2004 | EP1399555A2 Rank ligand-binding polypeptides |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399551A2 Method for separating bacterial cells and cell components |
| 03/24/2004 | EP1399550A2 Transgenic models for glucose homeostasis comprising human gsk-3 |